Primary Sclerosing Cholangitis Epidemiology in 7MM, 2017-2030: United States, Germany, Spain, Italy, France, UK and Japan

    NEXT STORY
    Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigen’s Scientific Advisory Board
    PREV STORY
    Global Immunoassay Markets, Strategies and Trends Report 2021: Multiplex and Point of Care Market Analysis & Forecasts 2019-2023
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer

    author_avatar
    NASDAQ Market News

    Clinical Results for BeyondSpring’s Lead Asset, Plinabulin for the Prevention of Chemotherapy-Induced Neutropenia, Demonstrated Superior Immune Profile Compared to Neulasta®

    Company to Present Latest Findings at 2018 Society for Immunotherapy of Cancer’s (SITC) Annual ...

    author_avatar
    NASDAQ Market News

    Novartis’ Xolair® recommended in new global chronic urticaria guideline

    Xolair® (omalizumab), indicated as add-on therapy for the treatment of chronic spontaneous urticaria (CSU)[1], ...

    author_avatar
    NASDAQ Market News